• About us
• Contact

Advertisement

Person › Details

Scott Koenig (MacroGenics Inc. (Nasdaq: MGNX))

Koenig, Scott (MacroGenics 200109– became SVP 5/06 is CEO before MedImmune)

 

	Organisation	MacroGenics Inc. (Nasdaq: MGNX)
	Group	MacroGenics (Group)
	Former/major organisation	MedImmune Inc. (Nasdaq: MEDI)
	Today	MedImmune (biologics division of AstraZeneca)
	Group	AstraZeneca (Group)

Record changed: 2019-02-11

Advertisement

More documents for Scott Koenig

• [1] MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.